{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:40:26Z","timestamp":1788306026652,"version":"build-2803163510"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T00:00:00Z","timestamp":1520294400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T00:00:00Z","timestamp":1520294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Austrian Society of Dermatology and Venereology"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1111\/bjd.16126","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T11:32:42Z","timestamp":1510831962000},"page":"1151-1162","source":"Crossref","is-referenced-by-count":45,"title":["Analysis of anti-tumour necrosis factor-induced skin lesions reveals strong T helper 1 activation with some distinct immunological characteristics"],"prefix":"10.1093","volume":"178","author":[{"given":"E.","family":"Stoffel","sequence":"first","affiliation":[{"name":"Department of Dermatology; Division of Immunology, Allergy and Infectious Diseases; Medical University of Vienna; Vienna Austria"},{"name":"Faculty of Medicine; University of Zurich; Zurich Switzerland"},{"name":"Department of Dermatology; University Hospital Zurich; Zurich Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Maier","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Division of General Dermatology; Medical University of Vienna; Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Riedl","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Division of General Dermatology; Medical University of Vienna; Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-C.","family":"Br\u00fcggen","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Division of Immunology, Allergy and Infectious Diseases; Medical University of Vienna; Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Reininger","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Division of Immunology, Allergy and Infectious Diseases; Medical University of Vienna; Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schaschinger","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Division of Immunology, Allergy and Infectious Diseases; Medical University of Vienna; Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bangert","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Division of Immunology, Allergy and Infectious Diseases; Medical University of Vienna; Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Guenova","sequence":"additional","affiliation":[{"name":"Faculty of Medicine; University of Zurich; Zurich Switzerland"},{"name":"Department of Dermatology; University Hospital Zurich; Zurich Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Stingl","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Division of Immunology, Allergy and Infectious Diseases; Medical University of Vienna; Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3488-3345","authenticated-orcid":false,"given":"P.M.","family":"Brunner","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Division of Immunology, Allergy and Infectious Diseases; Medical University of Vienna; Vienna Austria"},{"name":"Laboratory for Investigative Dermatology; The Rockefeller University; New York NY U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,3,6]]},"reference":[{"key":"10.1111\/bjd.16126-BIB0001|bjd16126-cit-0001","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","article-title":"Tumor necrosis factor antagonist mechanisms of action: a comprehensive review","volume":"117","author":"Tracey","year":"2008","journal-title":"Pharmacol Ther"},{"key":"10.1111\/bjd.16126-BIB0002|bjd16126-cit-0002","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/RHU.0b013e3182a702e8","article-title":"Psoriasiform reactions to anti-tumor necrosis factor alpha therapy","volume":"19","author":"Nguyen","year":"2013","journal-title":"J Clin Rheumatol"},{"key":"10.1111\/bjd.16126-BIB0003|bjd16126-cit-0003","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1365-2133.2009.09329.x","article-title":"Cytokine imbalance with increased production of interferon-alpha in psoriasiform eruptions associated with antitumour necrosis factor-alpha treatments","volume":"161","author":"Seneschal","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16126-BIB0004|bjd16126-cit-0004","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/gutjnl-2012-302853","article-title":"Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-gamma-expressing Th1 cells and IL-17A\/IL-22-expressing Th17 cells and respond to anti-IL-12\/IL-23 antibody treatment","volume":"63","author":"Tillack","year":"2014","journal-title":"Gut"},{"key":"10.1111\/bjd.16126-BIB0005|bjd16126-cit-0005","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/ajg.2015.205","article-title":"Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience","volume":"110","author":"Freling","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/bjd.16126-BIB0006|bjd16126-cit-0006","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cgh.2010.07.022","article-title":"Severe skin lesions cause patients with inflammatory bowel disease to discontinue anti-tumor necrosis factor therapy","volume":"8","author":"Rahier","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/bjd.16126-BIB0007|bjd16126-cit-0007","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000334805","article-title":"Eosinophilia during psoriasis treatment with TNF antagonists","volume":"223","author":"Malisiewicz","year":"2011","journal-title":"Dermatology"},{"key":"10.1111\/bjd.16126-BIB0008|bjd16126-cit-0008","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/09546634.2016.1230173","article-title":"Eczema as an adverse effect of anti-TNFalpha therapy in psoriasis and other Th1-mediated diseases: a review","volume":"28","author":"Nakamura","year":"2017","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/bjd.16126-BIB0009|bjd16126-cit-0009","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000235582","article-title":"Predictive factors of eczema-like eruptions among patients without cutaneous psoriasis receiving infliximab: a cohort study of 92 patients","volume":"219","author":"Esmailzadeh","year":"2009","journal-title":"Dermatology"},{"key":"10.1111\/bjd.16126-BIB0010|bjd16126-cit-0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.semarthrit.2010.04.003","article-title":"Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: clinical features and possible immunopathogenesis","volume":"40","author":"Collamer","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1111\/bjd.16126-BIB0011|bjd16126-cit-0011","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2133.2011.10583.x","article-title":"Efficacy of biologics in the treatment of moderate to severe psoriasis: a network meta-analysis of randomized controlled trials","volume":"166","author":"Reich","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16126-BIB0012|bjd16126-cit-0012","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000342503","article-title":"Anti-TNF-alpha induced psoriasiform eruptions with severe scalp involvement and alopecia: report of five cases and review of the literature","volume":"225","author":"Osorio","year":"2012","journal-title":"Dermatology"},{"key":"10.1111\/bjd.16126-BIB0013|bjd16126-cit-0013","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaad.2008.10.060","article-title":"Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical review","volume":"61","author":"Moustou","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16126-BIB0014|bjd16126-cit-0014","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1002\/eji.200838463","article-title":"IL-4-mediated fine tuning of IL-12p70 production by human DC","volume":"38","author":"Guenova","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1111\/bjd.16126-BIB0015|bjd16126-cit-0015","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jaci.2016.06.010","article-title":"Cellular and molecular immunologic mechanisms in patients with atopic dermatitis","volume":"138","author":"Werfel","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.16126-BIB0016|bjd16126-cit-0016","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/art.23835","article-title":"Psoriatic skin lesions induced by tumor necrosis factor antagonist therapy: a literature review and potential mechanisms of action","volume":"59","author":"Collamer","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1111\/bjd.16126-BIB0017|bjd16126-cit-0017","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archderm.143.2.223","article-title":"Psoriasis and pustular dermatitis triggered by TNF-{alpha} inhibitors in patients with rheumatologic conditions","volume":"143","author":"Gannes","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.16126-BIB0018|bjd16126-cit-0018","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1073\/pnas.0408506102","article-title":"Cross-regulation of TNF and IFN-alpha in autoimmune diseases","volume":"102","author":"Palucka","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/bjd.16126-BIB0019|bjd16126-cit-0019","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production","volume":"202","author":"Nestle","year":"2005","journal-title":"J Exp Med"},{"key":"10.1111\/bjd.16126-BIB0020|bjd16126-cit-0020","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1468-3083.2012.04582.x","article-title":"Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: a review and analysis of 36 cases","volume":"27","author":"Afshar","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.16126-BIB0021|bjd16126-cit-0021","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"Lande","year":"2007","journal-title":"Nature"},{"key":"10.1111\/bjd.16126-BIB0022|bjd16126-cit-0022","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jaad.2009.05.042","article-title":"A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti-interferon-alfa monoclonal antibody, in subjects with chronic psoriasis","volume":"62","author":"Bissonnette","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16126-BIB0023|bjd16126-cit-0023","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1097\/MIB.0000000000000198","article-title":"IL-36gamma sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease","volume":"20","author":"Friedrich","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/bjd.16126-BIB0024|bjd16126-cit-0024","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/exd.12709","article-title":"CCL7 contributes to the TNF-alpha-dependent inflammation of lesional psoriatic skin","volume":"24","author":"Brunner","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.16126-BIB0025|bjd16126-cit-0025","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/exd.12759","article-title":"Bioinformatics approach for choosing the correct reference genes when studying gene expression in human keratinocytes","volume":"24","author":"Beer","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.16126-BIB0026|bjd16126-cit-0026","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-4362.1994.tb01073.x","article-title":"Histologic grading system for psoriasis vulgaris","volume":"33","author":"Trozak","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.16126-BIB0027|bjd16126-cit-0027","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature14175","article-title":"Clinical improvement in psoriasis with specific targeting of interleukin-23","volume":"521","author":"Kopp","year":"2015","journal-title":"Nature"},{"key":"10.1111\/bjd.16126-BIB0028|bjd16126-cit-0028","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1016\/j.jid.2016.07.017","article-title":"In situ mapping of innate lymphoid cells in human skin: evidence for remarkable differences between normal and inflamed skin","volume":"136","author":"Bruggen","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.16126-BIB0029|bjd16126-cit-0029","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jaci.2013.05.036","article-title":"Infliximab induces downregulation of the IL-12\/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages","volume":"132","author":"Brunner","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.16126-BIB0030|bjd16126-cit-0030","doi-asserted-by":"crossref","first-page":"244ra90","DOI":"10.1126\/scitranslmed.3008946","article-title":"Intraindividual genome expression analysis reveals a specific molecular signature of psoriasis and eczema","volume":"6","author":"Quaranta","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1111\/bjd.16126-BIB0031|bjd16126-cit-0031","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1586\/1744666X.2015.996549","article-title":"NOS2 and CCL27: clinical implications for psoriasis and eczema diagnosis and management","volume":"11","author":"Garzorz","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1111\/bjd.16126-BIB0032|bjd16126-cit-0032","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jaci.2007.03.006","article-title":"Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasis","volume":"119","author":"Guttman-Yassky","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.16126-BIB0033|bjd16126-cit-0033","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.det.2014.09.002","article-title":"The immunopathogenesis of psoriasis","volume":"33","author":"Kim","year":"2015","journal-title":"Dermatol Clin"},{"key":"10.1111\/bjd.16126-BIB0034|bjd16126-cit-0034","doi-asserted-by":"crossref","first-page":"e101881","DOI":"10.1371\/journal.pone.0101881","article-title":"Dendritic cell-secreted lipocalin2 induces CD8+ T-cell apoptosis, contributes to T-cell priming and leads to a TH1 phenotype","volume":"9","author":"Floderer","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1111\/bjd.16126-BIB0035|bjd16126-cit-0035","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.intimp.2012.04.003","article-title":"Monocyte-derived interferon-alpha primed dendritic cells in the pathogenesis of psoriasis: new pieces in the puzzle","volume":"13","author":"Farkas","year":"2012","journal-title":"Int Immunopharmacol"},{"key":"10.1111\/bjd.16126-BIB0036|bjd16126-cit-0036","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.smim.2014.01.010","article-title":"Tissue-resident natural killer cells and their potential diversity","volume":"26","author":"Sojka","year":"2014","journal-title":"Semin Immunol"},{"key":"10.1111\/bjd.16126-BIB0037|bjd16126-cit-0037","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/exd.13077","article-title":"A novel molecular disease classifier for psoriasis and eczema","volume":"25","author":"Garzorz-Stark","year":"2016","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.16126-BIB0038|bjd16126-cit-0038","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.mehy.2016.04.042","article-title":"Targeting the IFN-gamma\/CXCL10 pathway in lichen planus","volume":"92","author":"Lernia","year":"2016","journal-title":"Med Hypotheses"},{"key":"10.1111\/bjd.16126-BIB0039|bjd16126-cit-0039","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/eji.1830200920","article-title":"The human intracellular Mx-homologous protein is specifically induced by type I interferons","volume":"20","author":"Wussow","year":"1990","journal-title":"Eur J Immunol"},{"key":"10.1111\/bjd.16126-BIB0040|bjd16126-cit-0040","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1001\/archderm.140.12.1490","article-title":"Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors","volume":"140","author":"Gilliet","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.16126-BIB0041|bjd16126-cit-0041","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-2443.2002.00515.x","article-title":"Requirement of the IFN-alpha\/beta-induced CXCR3 chemokine signalling for CD8+ T cell activation","volume":"7","author":"Ogasawara","year":"2002","journal-title":"Genes Cells"},{"key":"10.1111\/bjd.16126-BIB0042|bjd16126-cit-0042","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/rheumatology\/keh437","article-title":"Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-alpha inhibitors","volume":"44","author":"Aeberli","year":"2005","journal-title":"Rheumatology"},{"key":"10.1111\/bjd.16126-BIB0043|bjd16126-cit-0043","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2133.2011.10301.x","article-title":"Interferon-alpha in the generation of monocyte-derived dendritic cells: recent advances and implications for dermatology","volume":"165","author":"Farkas","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16126-BIB0044|bjd16126-cit-0044","doi-asserted-by":"crossref","first-page":"e17364","DOI":"10.1371\/journal.pone.0017364","article-title":"Interferon-alpha-conditioned human monocytes combine a Th1-orienting attitude with the induction of autologous Th17 responses: role of IL-23 and IL-12","volume":"6","author":"Santini","year":"2011","journal-title":"PLOS ONE"},{"key":"10.1111\/bjd.16126-BIB0045|bjd16126-cit-0045","doi-asserted-by":"crossref","first-page":"7302","DOI":"10.4049\/jimmunol.1002410","article-title":"A naturally occurring, soluble antagonist of human IL-23 inhibits the development and in vitro function of human Th17 cells","volume":"185","author":"Yu","year":"2010","journal-title":"J Immunol"},{"key":"10.1111\/bjd.16126-BIB0046|bjd16126-cit-0046","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJMoa021481","article-title":"Endogenous antimicrobial peptides and skin infections in atopic dermatitis","volume":"347","author":"Ong","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.16126-BIB0047|bjd16126-cit-0047","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/DAD.0b013e3181ef7403","article-title":"Psoriatic alopecia\/alopecia areata-like reactions secondary to anti-tumor necrosis factor-alpha therapy: a novel cause of noncicatricial alopecia","volume":"33","author":"Doyle","year":"2011","journal-title":"Am J Dermatopathol"},{"key":"10.1111\/bjd.16126-BIB0048|bjd16126-cit-0048","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/cei.12761","article-title":"Distinct expression of interleukin (IL)-36alpha, beta and gamma, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease","volume":"184","author":"Boutet","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/bjd.16126-BIB0049|bjd16126-cit-0049","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis","volume":"365","author":"Marrakchi","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.16126-BIB0050|bjd16126-cit-0050","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/eji.201242711","article-title":"The IL-36 receptor pathway regulates Aspergillus fumigatus-induced Th1 and Th17 responses","volume":"43","author":"Gresnigt","year":"2013","journal-title":"Eur J Immunol"},{"key":"10.1111\/bjd.16126-BIB0051|bjd16126-cit-0051","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1182\/blood-2011-05-356873","article-title":"IL-36R ligands are potent regulators of dendritic and T cells","volume":"118","author":"Vigne","year":"2011","journal-title":"Blood"},{"key":"10.1111\/bjd.16126-BIB0052|bjd16126-cit-0052","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jaci.2017.01.011","article-title":"The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies","volume":"139","author":"Brunner","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.16126-BIB0053|bjd16126-cit-0053","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jdermsci.2013.04.028","article-title":"The role of IL-22 and Th22 cells in human skin diseases","volume":"72","author":"Fujita","year":"2013","journal-title":"J Dermatol Sci"},{"key":"10.1111\/bjd.16126-BIB0054|bjd16126-cit-0054","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaci.2012.12.668","article-title":"The multifunctional role of filaggrin in allergic skin disease","volume":"131","author":"McAleer","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/bjd.16126-BIB0055|bjd16126-cit-0055","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2230.2006.02315.x","article-title":"Flare and change of psoriasis morphology during the course of treatment with tumour necrosis factor blockers","volume":"32","author":"Goiriz","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.16126-BIB0056|bjd16126-cit-0056","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1056\/NEJMoa1104200","article-title":"Mutual antagonism of T cells causing psoriasis and atopic eczema","volume":"365","author":"Eyerich","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.16126-BIB0057|bjd16126-cit-0057","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2340\/00015555-2636","article-title":"Pattern and severity of psoriasiform eruptions in patients with inflammatory bowel diseases, arthritis or skin inflammatory disorders treated with TNF-alpha inhibitors","volume":"97","author":"Darrigade","year":"2017","journal-title":"Acta Derm Venereol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.16126","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.16126\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:34:42Z","timestamp":1676381682000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/178\/5\/1151\/6753022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,6]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.16126","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3,6]]}}}